Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Spironolactone may help reduce hair growth and testosterone levels in some women with hirsutism.

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Spironolactone effectively reduces unwanted hair growth in women with hirsutism.

A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Treat hirsutism in premenopausal women with oral contraceptives and consider additional treatments if needed.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Surgery on a 68-year-old woman with an ovarian tumor led to reduced hirsutism and normal testosterone levels.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Bicalutamide shows promise for treating female hair loss.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Oral contraceptives help mild hirsutism, while flutamide and spironolactone help severe cases.

Surgical removal of a rare ovarian tumor improved symptoms and hormone levels in a postmenopausal woman.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Spironolactone reduces pain and lesions in hidradenitis suppurativa patients.

Oral contraceptives and antiandrogens are the best treatments for hirsutism.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.